Minister Reports Recall of 1,394 Drug Batches in 2023-24 Over Quality Failures
The number of drug batches recalled due to quality issues has increased from 950 in 2019-20 to a provisional 1,394…
cdsco
Read More
Cipla Receives CDSCO Approval to Launch Inhalable Insulin in India
Mumbai – Cipla Limited has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) to exclusively distribute and…
ASTRAZENECA GETS CDSCO APPROVAL TO IMPORT REVOLUTIONARY ANTI-CANCER DRUG “LYNPARZA”
AstraZeneca Pharma India has received CDSCO approval to import its anti-cancer drug Lynparza (olaparib) in 100 mg and 150 mg…
Central Drugs Standard Control Organization Joins IMDRF, Transforming India’s Medical Device Regulation for an Even Safer and Healthier Future
Central Drugs Standard Control Organization Joins International Medical Device Regulators Forum as Affiliate Member Central Drugs Standard Control Organization (CDSCO),…
“AstraZeneca India Secures CDSCO Approval: Expanding Breakthrough Life-Saving Chemotherapy Options to Empower Cancer Treatment”
AstraZeneca India Receives CDSCO Approval for Additional Indications of Its Chemotherapy Drug Astrazeneca, a leading biopharmaceutical company, has achieved a…